New Drug Approvals Archive - March 2007
Get news by email or subscribe to our news feeds.
March 2007
| March 2 |
Vaprisol (conivaptan hydrochloride)
New Indication Approved: February 28, 2007
Vaprisol (conivaptan hydrochloride) FDA Approval History |
| March 5 |
Tekturna (aliskiren) Tablets - formerly RasilezDate of Approval: March 5, 2007
Company: Novartis
Treatment for: Hypertension
Tekturna (aliskiren) is a direct renin inhibitor indicated as a once-daily oral therapy for the treatment of high blood pressure as monotherapy or in combination with other high blood pressure medications. Tekturna (aliskiren) FDA Approval History |
| March 13 |
Tykerb (lapatinib ditosylate) Tablets Date of Approval: March 13, 2007
Company: GlaxoSmithKline
Treatment for: Breast Cancer
Tykerb (lapatinib) is a kinase inhibitor indicated for the combination treatment of patients with advanced or metastatic breast cancer. Tykerb (lapatinib ditosylate) FDA Approval History |
| March 16 |
Soliris (eculizumab) Injection Date of Approval: March 16, 2007
Company: Alexion Pharmaceuticals, Inc.
Treatment for: Paroxysmal Nocturnal Hemoglobinuria
Soliris (eculizumab) is a monoclonal antibody indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis, and for the treatment of patients with atypical hemolytic uremic syndrome. Soliris (eculizumab) FDA Approval History |
| March 30 |
Ceprotin (protein C) Injection Date of Approval: March 30, 2007
Company: Baxter Healthcare Corporation
Treatment for: Protein C Deficiency
Ceprotin is a plasma-derived Protein C concentrate for use as replacement therapy in patients with life-threatening blood-clotting complications related to severe congenital Protein C deficiency. Ceprotin (protein C) FDA Approval History |
| March 30 |
Janumet (metformin and sitagliptin) Tablets Date of Approval: March 30, 2007
Company: Merck & Co., Inc.
Treatment for: Diabetes Type 2
Janumet is a combination of the oral antihyperglycemic drugs sitagliptin and metformin indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Janumet (metformin and sitagliptin) FDA Approval History |
| February 1 |
Tykerb (lapatinib ditosylate)
New Indication Approved: January 29, 2010
Tykerb (lapatinib ditosylate) FDA Approval History |
| September 23 |
New Indication Approved: September 23, 2011
Soliris (eculizumab) FDA Approval History |
| February 2 |
Janumet (metformin and sitagliptin)
New Formulation Approved: February 2, 2012
Janumet (metformin and sitagliptin) FDA Approval History |
New Drug Approvals Archive
2016
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2015
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2014
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2013
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2012
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2011
January,
February,
March,
April,
May,
June,
July,
August,
October,
November,
December2010
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2009
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2008
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2007
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2006
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2005
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2004
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2003
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December
